Idaho Attorney General Raúl Labrador announced a consent decree on Thursday mandating the separation of Kootenai Health and Syringa Hospital and Clinics. This action is part of a broader antitrust push aimed at curbing the rising trend of hospital system consolidation, which has been prevalent across the nation for decades.
The roots of this decree trace back to several acquisitions and agreements made by Kootenai Health in recent years. In 2020, Kootenai Health expanded its reach by purchasing Clearwater Valley Hospital in Orofino and St. Mary’s Hospital in Cottonwood. Prior to these acquisitions, Kootenai Health entered into a management agreement with Syringa Hospital in Grangeville in 2017. This agreement notably made Syringa’s CEO an employee of Kootenai Health.
The Attorney General’s office highlighted the antitrust concerns arising from this arrangement, noting that Kootenai Health gained access to Syringa’s significant competitively sensitive non-public information through the management agreement. Such access raised substantial antitrust issues, prompting the intervention.
The newly issued consent decree explicitly requires Kootenai Health to terminate all existing contracts with Syringa Hospital. Any future agreements between the two entities will necessitate prior approval from the Attorney General, ensuring stricter oversight.
However, the decree does not address Kootenai Health’s ownership of St. Mary’s Hospital and Clearwater Valley Hospital. In response to inquiries, NonStop Local reached out to the Idaho Attorney General’s Office to verify whether Kootenai Health retains ownership of these hospitals following the consent decree. As of now, the status of these ownerships remains unconfirmed.
Source: KHQ
Featured News
NFL Found Guilty of Antitrust Violations in ‘Sunday Ticket’ Trial, Must Pay $4.8 Billion
Jun 27, 2024 by
CPI
StarKist and Former Bumble Bee Foods Owner Settle US Price-Fixing Suit
Jun 27, 2024 by
CPI
Senate Probes Oil Giants for Price-Fixing with OPEC
Jun 27, 2024 by
CPI
Spain to Lodge Anti-Competitive Complaint Against French Rail Operator Ouigo
Jun 27, 2024 by
CPI
Jury Deliberates NFL’s ‘Sunday Ticket’ Class-Action Lawsuit
Jun 27, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI